Target intelligence / Profile preview

Death domain-associated protein 6 (DAXX)

Target
DAXX
Molecular classification
Histone chaperone, Chromatin-associated protein, Transcriptional corepressor, Apoptosis-related protein, Other
01

Overview

Death domain-associated protein 6 (DAXX) is a multifunctional nuclear and cytoplasmic protein that acts principally as a histone chaperone specific for the replication-independent histone variant H3.3, regulating chromatin assembly and structure, gene transcription, and apoptosis[1][2][3][4]. DAXX interacts with ATRX to mediate H3.3 deposition at pericentromeric heterochromatin and telomeres, thereby affecting genome stability and telomere maintenance[1][2][3][4]. In the nucleus, DAXX also functions as a potent transcriptional corepressor through interaction with sumoylated transcription factors and chromatin proteins and localizes to promyelocytic leukemia nuclear bodies (PML-NBs)[1][3]. In the cytoplasm, DAXX was initially identified as a Fas-interacting protein that promotes apoptosis through the JNK pathway but can also mediate anti-apoptotic effects depending on context, such as its subcellular localization and binding partners[3][5]. Dysregulation, mislocalization, or overexpression of DAXX is implicated in multiple cancer types and may be linked to disease progression, prognosis, and potential therapeutic targeting[5].

Other names
DAXXDAP6hDaxxBING2EAP1SMIM40ETS1-associated protein 1Fas death domain-associated proteinFas-binding proteinCENP-C binding protein
02

Biological functions

Chromatin regulationHistone variant H3.3 depositionTranscription repression/corepressionApoptosis (cell death)Cell cycle regulationTelomere maintenanceSignal transduction
03

Disease associations

CancerNeurodegenerationOther (e.g., roles in viral defense)
04

Safety considerations

Altering subcellular localization of DAXX (nuclear vs. cytoplasmic) may have opposite effects on tumor progression and apoptosis, posing therapeutic complexity[5]
05

Biomarkers

Nuclear/cytoplasmic DAXX ratio in gastric cancer as a prognostic indicator[5]DAXX expression levels may serve as a biomarker in certain tumor types[5]

Beyond the preview

Go deeper on Death domain-associated protein 6 (DAXX).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Death domain-associated protein 6 (DAXX).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call